News Releases

Beckman Coulter announced today commercialization of DxONE Inventory Manager, its automated, cloud-based software technology that simplifies inventory management and enhances operational...

Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, is embarking on an innovation collaboration with Johns Hopkins Medicine to explore co-innovation initiatives with...

Featuring innovative technology, these diagnostic tools will help enhance analysis and detection for critical blood-based conditions and diseases for patients across the country BREA, Calif.,...

Beckman Coulter today announced the release of its newest software version for the company's flagship middleware system, REMISOL Advance. The software iteration features enhancements—designed in...

Beckman Coulter, a global leader in the clinical diagnostics industry, announced today that it is a gold sponsor of the 2nd World Sepsis Congress, a free-of-charge online conference, hosted by the...

Beckman Coulter announced today commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing for microbiology...

Beckman Coulter and U.S. ARKRAY, Inc. (ARKRAY) announced a new partnership and the launch of the iQ Urinalysis Workcell. The iQ Workcell pairs two of the world's most highly regarded automated...

Beckman Coulter Diagnostics goes beyond technology to help laboratories face challenges in the current healthcare environment BREA, Calif. — (July 20, 2018) — Beckman Coulter, a global leader...

Beckman Coulter Diagnostics announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new high-sensitivity troponin (hsTnI) assay, Access hsTnI, for...

New assay enables hospitals to provide efficiency improvements in cardiac patient management BREA, Calif. — (June 26, 2018) — Beckman Coulter Diagnostics announced today that it has received...